Target intelligence / Profile preview

T cell surface glycoprotein CD3 complex chain delta (CD3δ)

Target
CD3δ
Molecular classification
Glycoprotein, Cluster of differentiation (CD3 subunit), Component of T cell receptor (TCR) complex, Signal transduction molecule
01

Overview

The T cell surface glycoprotein CD3 complex chain delta (CD3δ) is one of four invariant chains (γ, δ, ε, ζ) of the CD3 complex, which is essential for surface expression and signal transduction of the T cell receptor (TCR) complex. The CD3 complex stabilizes the TCR on the surface of all mature T cells and transduces signals following antigen recognition. CD3δ forms a dimer with CD3ε as part of the functional CD3 structure, enabling the transmission of activation signals via immunoreceptor tyrosine-based activation motifs (ITAMs) in their cytoplasmic domains. CD3δ is required for normal T cell development, activation, and effector function; mutations or loss of CD3δ expression results in immunodeficiency. The CD3 complex, including the delta chain, is a major target for monoclonal antibody therapies in transplantation, autoimmune diseases, and cancer immunotherapy.

Other names
CD3 delta chainCD3δCD3D (gene symbol)T3 delta chain
02

Mechanism of action

Monoclonal antibodies against CD3 trigger T cell depletion, activation, or anergy by binding to the CD3 complex, leading to signaling dysregulation, cell death, or immune modulation. Agonism or antagonism of the TCR/CD3 complex for immunosuppression or immunostimulation.

03

Biological functions

T cell activationSignal transductionCell-mediated immune responseSurface expression of the TCR/CD3 complex
04

Disease associations

Cancer (immunotherapy target; part of T cell activation pathway)Infection (central in adaptive immunity)Autoimmune disease (therapeutic modulation of T cell responses)Other (general immune dysregulation)
05

Safety considerations

Cytokine release syndrome (CRS; notable risk with anti-CD3 therapies)Immune suppression/infection risk (therapeutic antibodies)Off-target immune modulation
06

Interacting drugs

Muromonab-CD3 (OKT3; anti-CD3 monoclonal antibody, which targets the CD3 epsilon chain but functionally affects the entire CD3 complex including delta)

3 more in the full profile.

07

Biomarkers

CD3 expression (used to enumerate T cells in diagnostics and monitor immune depletion/activation)CD3D mRNA/protein levels (sometimes measured for research or diagnostic purposes)

Beyond the preview

Go deeper on T cell surface glycoprotein CD3 complex chain delta (CD3δ).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on T cell surface glycoprotein CD3 complex chain delta (CD3δ).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call